Sangamo Therapeutics Announces Participation At Upcoming Investor Conferences

BRISBANE, Calif., March 6, 2019 /PRNewswire/ -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will participate in the following healthcare investor conferences in March:

• Cowen 39th Annual Health Care ConferencePresentation Date: Tuesday, March 12th at 8:40 a.m. Eastern TimeLocation: Boston, MA
• Barclays 2019 Global Healthcare ConferencePresentation Date: Thursday, March 14th at 8:00 a.m. Eastern TimeLocation: Miami, FL
• ARM 7th Annual Cell & Gene Investor DayPresentation Date: Thursday, March 21st at 2:45 p.m. Eastern TimeLocation: New York, NY

The presentations will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentations will be archived on the Sangamo website for two weeks after the events.

About Sangamo Therapeutics Sangamo Therapeutics, Inc. is focused on translating ground-breaking science into genomic medicines with the potential to transform patients' lives using the Company's platform technologies in genome editing, gene therapy, gene regulation and cell therapy. For more information about Sangamo, visit www.sangamo.com.

View original content to download multimedia:http://www.prnewswire.com/news-releases/sangamo-therapeutics-announces-participation-at-upcoming-investor-conferences-300807944.html

SOURCE Sangamo Therapeutics, Inc.